James C. Czirr

Major shareholder at Galectin Therapeutics · 11 reported transactions in 1 company · latest report Jun 6, 2025

Their trades


Galectin TherapeuticsGALT	Exercised options $44.4K · 40,000 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $79.2K · 40,000 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $147.7K · 70,000 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $84.4K · 40,000 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $85.8K · 30,000 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $118K · 25,000 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $112K · 46,875 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Exercised options $27.8K · 31,250 shares	Jun 6, 2025
Galectin TherapeuticsGALT	Other $6K · 1,000 shares	Mar 31, 2025
Galectin TherapeuticsGALT	Gift — · 10,000 shares	Feb 4, 2025

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$44.4K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$79.2K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$147.7K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$84.4K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$85.8K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$118K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$112K

Exercised optionsGalectin Therapeutics

Jun 6, 2025 · GALT

$27.8K

OtherGalectin Therapeutics

Mar 31, 2025 · GALT

$6K

GiftGalectin Therapeutics

Feb 4, 2025 · GALT

10,000

Newest 10 of 11 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.